Research Presentation Session

RPS 311 - Cancer in neuroradiology

Lectures

1
RPS 311 - Noninvasive differentiation of molecular subtypes of non-enhancing glioma using MRI perfusion and diffusion parameters

RPS 311 - Noninvasive differentiation of molecular subtypes of non-enhancing glioma using MRI perfusion and diffusion parameters

04:44I. Pruis, Rotterdam / Netherlands

2
RPS 311 - Imaging-based classification of glioma, it’s validation with survival analysis and integration with new WHO genetic glioma classification

RPS 311 - Imaging-based classification of glioma, it’s validation with survival analysis and integration with new WHO genetic glioma classification

05:30A. Kamble, New Delhi / India

3
RPS 311 - Diagnostic accuracy of ASL in comparison with DSC perfusion in the surveillance of different types of brain tumours

RPS 311 - Diagnostic accuracy of ASL in comparison with DSC perfusion in the surveillance of different types of brain tumours

02:41A. Lavrova, St. Petersburg / Russia

4
RPS 311 - Combination of magnetic resonance relaxometry and ASL perfusion in assessment of high-grade glioma subregions and surrounding brain tissue

RPS 311 - Combination of magnetic resonance relaxometry and ASL perfusion in assessment of high-grade glioma subregions and surrounding brain tissue

04:53I. Chekhonin, Moscow / Russia

5
RPS 311 - Assessment of subcortical brain volume changes in breast cancer patients undergoing treatment: a pilot study

RPS 311 - Assessment of subcortical brain volume changes in breast cancer patients undergoing treatment: a pilot study

04:39Ana Verde, Lisboa / Portugal

6
RPS 311 - Improved imaging of therapy-naive high-grade glioma by turbo spin-echo black blood sequences

RPS 311 - Improved imaging of therapy-naive high-grade glioma by turbo spin-echo black blood sequences

04:18N. Sollmann, Munich / Germany

7
RPS 311 - ASL for brain tumours: do we really need CBF maps?

RPS 311 - ASL for brain tumours: do we really need CBF maps?

04:32W. Teunissen, Rotterdam / Netherlands

8
RPS 311 - Comparison of capability for molecular-based assessment in various brain tumour patients between 3D gradient echo-based CEST imaging and 2D spin echo-based CEST imaging

RPS 311 - Comparison of capability for molecular-based assessment in various brain tumour patients between 3D gradient echo-based CEST imaging and 2D spin echo-based CEST imaging

04:26K. Murayama, Toyoake, Aichi / Japan

9
RPS 311 - Image subtraction maps for longitudinal FLAIR imaging in patients with glioma may facilitate early detection of tumour progression

RPS 311 - Image subtraction maps for longitudinal FLAIR imaging in patients with glioma may facilitate early detection of tumour progression

04:41N. Sollmann, Munich / Germany

10
RPS 311 - Diffusion tensor imaging (DTI): a better understanding of spinal cord tumours

RPS 311 - Diffusion tensor imaging (DTI): a better understanding of spinal cord tumours

04:58A. Ignatius, Chennai / India

11
RPS 311 - Comparative analysis of arterial spin labeling and dynamic contrast perfusion imaging for quantitative perfusion measurements of brain tumours

RPS 311 - Comparative analysis of arterial spin labeling and dynamic contrast perfusion imaging for quantitative perfusion measurements of brain tumours

04:56S. Ahmed, Jodhpur / India

12
RPS 311 - Intracranial cystic lesions: wherever there is fluid

RPS 311 - Intracranial cystic lesions: wherever there is fluid

05:25F. Badi, Casablanca / Morocco

13
RPS 311 - Recurrence assessment in glioblastoma: 11C-methionine PET vs perfusion magnetic resonance imaging (MRI)

RPS 311 - Recurrence assessment in glioblastoma: 11C-methionine PET vs perfusion magnetic resonance imaging (MRI)

05:02A.C. Igual Rouilleault, Pamplona / Spain

PEP Subscription Required

This course is only accessible for ESR Premium Education Package subscribers.